Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8+ Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)
Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step of tryptophan catabolism in a specific pathway, resulting in a series of extracellular messengers collectively known as kynurenines. IDO has been recognized as an authentic regulator of immunity not only in mammalian preg...
Main Authors: | Pallotta, Maria T., Orabona, Ciriana, Volpi, Claudia, Grohmann, Ursula, Puccetti, Paolo, Fallarino, Francesca |
---|---|
Format: | Online |
Language: | English |
Published: |
Libertas Academica
2010
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195250/ |
Similar Items
-
Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
by: Albini, Elisa, et al.
Published: (2016) -
Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1
by: Romani, Rita, et al.
Published: (2015) -
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
by: Moon, Yong Wha, et al.
Published: (2015) -
Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer
by: Chen, I-Chien, et al.
Published: (2016) -
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
by: Zhao, Fei, et al.
Published: (2014)